Search Results

Vecuronium Bromide 100 mg  | ≥98%

LKT Laboratories, Inc.

Non-depolarizing NMJ blocker; nAChR antagonist.

More Information Supplier Page

×

Vecuronium Bromide

Vecuronium Bromide 50 mg  | ≥98%

LKT Laboratories, Inc.

Non-depolarizing NMJ blocker; nAChR antagonist.

More Information Supplier Page

×

Vecuronium Bromide

Vecuronium Bromide 10 mg  | ≥98%

LKT Laboratories, Inc.

Non-depolarizing NMJ blocker; nAChR antagonist.

More Information Supplier Page

×

Vecuronium Bromide

Catharanthine base 500 mg  | ≥98%

LKT Laboratories, Inc.

Alkaloid found in Catharanthus, precursor in synthesis of vinca alkaloids; voltage-gated Ca2+ channel blocker.

More Information Supplier Page

×

Catharanthine base

Vatalanib Dihydrochloride 5 mg  | ≥98%

LKT Laboratories, Inc.

VEGFR inhibitor.

More Information Supplier Page

×

Vatalanib Dihydrochloride

Vatalanib Dihydrochloride 10 mg  | ≥98%

LKT Laboratories, Inc.

VEGFR inhibitor.

More Information Supplier Page

×

Vatalanib Dihydrochloride

Ceftriaxone Sodium 1 g  | ≥98%

LKT Laboratories, Inc.

β-lactam cephalosporin; penicillin binding protein inhibitor.

More Information Supplier Page

×

Ceftriaxone Sodium

Ceftriaxone Sodium 500 mg  | ≥98%

LKT Laboratories, Inc.

β-lactam cephalosporin; penicillin binding protein inhibitor.

More Information Supplier Page

×

Ceftriaxone Sodium

Ceftriaxone Sodium 250 mg  | ≥98%

LKT Laboratories, Inc.

β-lactam cephalosporin; penicillin binding protein inhibitor.

More Information Supplier Page

×

Ceftriaxone Sodium

Vandetanib 100 mg  | ≥98%

LKT Laboratories, Inc.

RET, EGFR, VEGFR2 inhibitor.

More Information Supplier Page

×

Vandetanib